腰椎骨赘在68Ga-前列腺特异性膜抗原PET/CT上摄取增高
一名75岁新诊断高危前列腺癌男性接受68Ga-PSMA PET/CT原发分期,右侧L2/L3水平骨赘显示强烈68Ga-PSMA摄取,而其他脊柱骨赘无摄取;MRI示L3椎体良性Modic 1型病变,但高摄取骨赘处MRI无恶性征象。
要点
- 骨赘可表现为68Ga-PSMA PET/CT上的良性摄取 pitfalls
- 同一脊柱其他骨赘无68Ga-PSMA摄取,摄取分布不均匀
- MRI有助于鉴别:高摄取骨赘处无恶性征象
核心结论
- 骨赘应作为解读68Ga-PSMA PET/CT时需注意的潜在良性 pitfalls 之一。
研究设计与样本
- 病例报告:一名75岁新诊断高危前列腺癌男性,因原发分期接受68Ga-PSMA PET/CT检查。
主要发现
- 68Ga-PSMA PET/CT显示右侧L2/L3水平骨赘强烈摄取68Ga-PSMA,而其他多个脊柱骨赘无68Ga-PSMA摄取。
- MRI示L3椎体病变符合良性Modic 1型,但高68Ga-PSMA摄取骨赘处MRI无恶性征象。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 75-year-old man with recently diagnosed high-risk prostate cancer was referred for primary staging with Ga-prostate-specific membrane antigen (PSMA) PET/CT. The scan revealed intense Ga-PSMA uptake in a lumbar osteophyte on the right side of level L2/L3, whereas several other spinal osteophytes showed no Ga-PSMA uptake. MRI findings in the L3 vertebra was consistent with a benign Modic type 1 lesion, but MRI showed no signs of malignancy in the osteophyte with high Ga-PMSA uptake. This case presents an osteophyte as an addition to the list of potential benign pitfalls to be aware of when interpreting Ga-PSMA PET/CT.
引用
- Jochumsen MR, Madsen MA, Gammelgaard L, et al. Lumbar Osteophyte Avid on 68Ga-Prostate-Specific Membrane Antigen PET/CT. Clin Nucl Med. 2018. PMID: 29538033. doi:10.1097/RLU.0000000000002065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。